As usual, this year’s American Diabetes Association Scientific Sessions didn’t place much emphasis on a healthy lifestyle. There was food everywhere, and trust me, we’re not talking fruits & veggies. But there was a great deal of research presented on diabetes medications and devices.
There is no doubt that CGM can improve the quality of life and blood sugar control for just about everyone with diabetes. But which system is best for you?
IDS Clinicians Offer Different Perspectives on the Medtronic 670G after 10 days of use. Read what they have to say...
The 670G represents an important step towards fully automating glucose control. However, it is important to put it in the proper context and set expectations at an appropriate level.
The National Diabetes Statistics Report from the Centers for Disease Control and Prevention shows that 29 million Americans have diabetes, and 95 percent of them have Type 2, the form most associated with obesity. And interestingly the number of people age 20 or older with diabetes topped 1.7 million. It is also estimated that 86 million Americans 20 years and older may have prediabetes which increases the risk of developing Type 2 diabetes. The increase in incidence of diabetes (both type 1 and type 2) provides a lot of incentive for developers of Apps to create products to aid with management of chronic health conditions like diabetes. A study published in the journal Clinical Diabetes showed that “the use of mobile phones leads to improved A1C and self-management in diabetes care.”, assuming this is due to apps that aid with improved tracking and awareness of glucose patterns. In a basic count recently, I found 1000+ apps specific to diabetes management – WOW! Great that so much is available, but how can a person with diabetes figure out which app is right for them? Depending on the needs of the individual, health apps can be very beneficial, especially from the standpoint of possible support. However, the person choosing the App needs to consider what they want or need to track as well as how tech-savvy they are, which can improve how they manage. Step one in this process of choice should be to narrow down the apps based on your individual goals. For some people that might be a focus on weight control, while others need help tracking blood glucose and learning about their patterns. Some apps also help you to remember to take medication, change [...]
It's awesome that people with diabetes are living normal lifespans, but the current Medicare system is not set up to provide coverage of the technologies that we become accustomed to using when we have commercial insurance coverage to control the disease as well as we can.
Heading back to school is an exciting and anxious time for most and no doubt diabetes can add to that anxiety level. Whether your child is very young, newly diagnosed or maybe just heading to a new school this year, the thought of going back to school may have you both on edge.
There are a multitude of different groups working on hybrid closed loop projects, and each one runs on its own unique proportion of automation and brain-power. Here are a few of the projects that were presented and discussed at the ADA Scientific Sessions in New Orleans this past June.
My name is Jacob Seltzer, I am 20 years old, and a Type 1 Diabetic. I was diagnosed with diabetes on my half birthday, November 21, 2011 at the age of 15. I have had diabetes for roughly 5 years and I do not let it get in my way. I am currently going into my junior year of college at Stony Brook University as an athletic training major.
You go to bed and your blood sugar level is perfect....Ahhh. Then you wake up and it's awful?! What happened??. Find out the 4 Reasons Why Blood Sugar Can Be High in the Morning
How do the latest Medtronic and Dexcom CGM systems compare?
Scott Benner is a stay-at-home Dad, a storyteller, a type 1 diabetes advocate and an author.
It is with great pleasure that we have a special opportunity to post Dr. Steve Edelman & Dr. Jeremy Pettus's ADA recap from the recent ADA Scientific Sessions in Boston.